Nu-Med Plus (NUMD) Share-based Compensation Growth (5y) (2017 - 2022)
Nu-Med Plus (NUMD) Share-based Compensation Growth (5y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 7.00% |
| Dec 31, 2021 | -34.40% |
| Dec 31, 2020 | -4.55% |
| Sep 30, 2020 | -30.30% |
| Mar 31, 2020 | 161.49% |
| Dec 31, 2019 | -47.55% |
| Sep 30, 2019 | -24.16% |
| Jun 30, 2019 | -28.97% |
| Mar 31, 2019 | 69.03% |
| Sep 30, 2018 | 70.00% |
| Dec 31, 2017 | -20.03% |
| Sep 30, 2017 | -5.91% |